(1)
Dmytrenko, I. V.; Minchenko, Z. M.; Fedorenko, V. V.; Dyagil, I. S. SIGNIFICANCE OF ADDITIONAL CHROMOSOMAL ABNORMALITIES FOR THE OUTCOMES AFTER THE SECOND LINE NILOTINIB THERAPY IN THE CHRONIC MYELOID LEUKEMIA PATIENTS. IJMMR 2019, 5, 33-39.